Literature DB >> 10972337

Exposure to tissue culture conditions can adversely affect myoblast behavior in vivo in whole muscle grafts: implications for myoblast transfer therapy.

G M Smythe1, M D Grounds.   

Abstract

The effects of tissue culture conditions on the viability of myoblasts in whole muscles transplanted in vivo were investigated. Whole male (SJL/J) donor muscles were exposed to various tissue culture reagents and proteolytic enzymes, and allografted into female (SJL/J) host mice. Desmin immunohistochemistry was used to assess the numbers of myogenic cells (as an index of myoblast viability and the extent of regeneration) in tissue sections of whole-muscle grafts sampled on days 7 and 14. DNA quantitation with a Y-chromosome-specific probe was used to determine the total Y-1 sequence DNA (as an index of myoblast survival and proliferation) in whole-muscle grafts sampled on days 1, 3, and 7. In grafts exposed to serum-free medium, there was a delay in myoblast fusion at 7 days that was recovered by 14 days, but exposure to serum (10% or 20%) had a prolonged adverse effect on myotube formation at 14 days. DNA quantitation demonstrated that either serum-free culture medium or 10% serum enhanced the number of male cells within whole-muscle grafts at 7 days. Proteolytic digestion (even for 5 min) of whole muscles prior to grafting was extremely detrimental to myoblast survival and viability at 7 and 14 days. The unexpected finding of adverse effects of tissue culture conditions on the regeneration of whole-muscle grafts in vivo appears to parallel the major problem of the rapid death of isolated cultured donor myoblasts after injection in myoblast transfer therapy. The use of whole-muscle grafts provides an alternative and sensitive model to analyze the crucial effects of various tissue culture components on the subsequent survival and proliferation of myogenic cells in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10972337     DOI: 10.1177/096368970000900309

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  7 in total

1.  Milieu-based versus gene-modulatory strategies for directing stem cell differentiation--A major issue of contention in transplantation medicine.

Authors:  Boon Chin Heng; Tong Cao
Journal:  In Vitro Cell Dev Biol Anim       Date:  2006 Mar-Apr       Impact factor: 2.416

2.  Harnessing the therapeutic potential of myogenic stem cells.

Authors:  Jason D White; Miranda D Grounds
Journal:  Cytotechnology       Date:  2003-03       Impact factor: 2.058

3.  Defining the heterogeneity of skeletal muscle-derived side and main population cells isolated immediately ex vivo.

Authors:  Kristen M Kallestad; Linda K McLoon
Journal:  J Cell Physiol       Date:  2010-03       Impact factor: 6.384

4.  Cell-based therapy for urinary incontinence.

Authors:  Jae Hyun Bae; James J Yoo
Journal:  Korean J Urol       Date:  2010-01-21

Review 5.  New directions in strategies using cell therapy for heart disease.

Authors:  Silviu Itescu; Michael D Schuster; Alfred A Kocher
Journal:  J Mol Med (Berl)       Date:  2003-04-16       Impact factor: 4.599

Review 6.  Therapeutic potentials of human embryonic stem cells in Parkinson's disease.

Authors:  Mary B Newman; Roy A E Bakay
Journal:  Neurotherapeutics       Date:  2008-04       Impact factor: 7.620

Review 7.  Context matters: in vivo and in vitro influences on muscle satellite cell activity.

Authors:  D D W Cornelison
Journal:  J Cell Biochem       Date:  2008-10-15       Impact factor: 4.429

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.